A tale of three labels: translating the JUPITER trial data into regulatory claims. [electronic resource]
Producer: 20120223Description: 417-22 p. digitalISSN:- 1740-7753
- Aged
- Aged, 80 and over
- Canada
- Cardiovascular Diseases -- prevention & control
- Drug Labeling -- legislation & jurisprudence
- Drug and Narcotic Control
- Europe
- Female
- Fluorobenzenes -- therapeutic use
- Government Regulation
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Male
- Middle Aged
- Pyrimidines -- therapeutic use
- Randomized Controlled Trials as Topic
- Rosuvastatin Calcium
- Sulfonamides -- therapeutic use
- Translational Research, Biomedical
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.